Literature DB >> 1355427

Effects of loratadine and cetirizine on actual driving and psychometric test performance, and EEG during driving.

J G Ramaekers1, M M Uiterwijk, J F O'Hanlon.   

Abstract

Sixteen healthy male and female volunteers took part in a 6-way, double-blind cross-over trial to compare the effects of single doses of cetirizine 10 mg, loratadine 10 mg and placebo, with and without alcohol (0.72 g.kg-1, lean body mass). Performance was measured in two repetitions of a psychometric test battery, and a standard, over-the-road driving test. EEG was also measured during driving. Alcohol significantly affected almost every performance measure and altered the EEG energy spectrum during driving whilst the blood concentrations declined from 0.37 to 0.20 mg.ml-1. The effects of cetirizine of on driving performance resembled those of alcohol. It caused the subjects to operate with significantly greater variability in speed and lateral position ('weaving' motion). The effects of alcohol and cetirizine appeared to be additive. Certain cetirizine-placebo differences in subjective feelings and test battery performance were also significant. Loratadine had no significant effect on any performance parameter. It was concluded that cetirizine, but not loratadine, generally caused mild impairment of performance after a single 10 mg dose.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1355427     DOI: 10.1007/bf00280119

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  7 in total

1.  Quantitative effects of cetirizine and diphenhydramine on mental performance measured using an automobile driving simulator.

Authors:  F M Gengo; C Gabos; L Mechtler
Journal:  Ann Allergy       Date:  1990-06

Review 2.  Chronic urticaria: review of nonsedating H1 antihistamines in treatment.

Authors:  E W Monroe
Journal:  J Am Acad Dermatol       Date:  1988-11       Impact factor: 11.527

3.  Pharmacokinetics and dose proportionality of loratadine.

Authors:  J Hilbert; E Radwanski; R Weglein; V Luc; G Perentesis; S Symchowicz; N Zampaglione
Journal:  J Clin Pharmacol       Date:  1987-09       Impact factor: 3.126

4.  Memory-scanning: mental processes revealed by reaction-time experiments.

Authors:  S Sternberg
Journal:  Am Sci       Date:  1969       Impact factor: 0.548

5.  Driving performance under the influence of drugs: rationale for, and application of, a new test.

Authors:  J F O'Hanlon
Journal:  Br J Clin Pharmacol       Date:  1984       Impact factor: 4.335

Review 6.  Cetirizine. A review of its pharmacological properties and clinical potential in allergic rhinitis, pollen-induced asthma, and chronic urticaria.

Authors:  D M Campoli-Richards; M M Buckley; A Fitton
Journal:  Drugs       Date:  1990-11       Impact factor: 9.546

7.  Cetirizine effects on objective measures of daytime sleepiness and performance.

Authors:  W F Seidel; S Cohen; N G Bliwise; W C Dement
Journal:  Ann Allergy       Date:  1987-12
  7 in total
  27 in total

Review 1.  Cetirizine: a review of its use in children with allergic disorders.

Authors:  C M Spencer; S Noble
Journal:  Paediatr Drugs       Date:  1999 Jan-Mar       Impact factor: 3.022

Review 2.  New insights into the second generation antihistamines.

Authors:  G M Walsh; L Annunziato; N Frossard; K Knol; S Levander; J M Nicolas; M Taglialatela; M D Tharp; J P Tillement; H Timmerman
Journal:  Drugs       Date:  2001       Impact factor: 9.546

3.  Repeated-dose effects of mequitazine, cetirizine and dexchlorpheniramine on driving and psychomotor performance.

Authors:  Eef L Theunissen; Annemiek Vermeeren; Johannes G Ramaekers
Journal:  Br J Clin Pharmacol       Date:  2006-01       Impact factor: 4.335

4.  Lapses of attention as outcome measure of the on-the-road driving test.

Authors:  Joris C Verster; Adriana C Bervoets; Suzanne de Klerk; Thomas Roth
Journal:  Psychopharmacology (Berl)       Date:  2013-08-24       Impact factor: 4.530

5.  Statistical test of VEP waveform equality.

Authors:  Rockefeller S L Young; Eiji Kimura
Journal:  Doc Ophthalmol       Date:  2009-12-02       Impact factor: 2.379

6.  Histamine H1 receptor antagonist cetirizine impairs working memory processing speed, but not episodic memory.

Authors:  P van Ruitenbeek; A Vermeeren; W J Riedel
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

7.  A pharmacokinetic profile of desloratadine in healthy adults, including elderly.

Authors:  Melton Affrime; Samir Gupta; Christopher Banfield; Albert Cohen
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

8.  Effects of roxithromycin on the pharmacokinetics of loratadine after oral and intravenous administration of loratadine in rats.

Authors:  Cheng Li; Cheul-Seol Kim; Jeong-Yeol Yang; Yeong-Jin Park; Jun-Shik Choi
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2008 Oct-Dec       Impact factor: 2.441

9.  Lack of interaction between a new antihistamine, mizolastine, and lorazepam on psychomotor performance and memory in healthy volunteers.

Authors:  A Patat; M C Perault; B Vandel; N Ulliac; I Zieleniuk; P Rosenzweig
Journal:  Br J Clin Pharmacol       Date:  1995-01       Impact factor: 4.335

10.  Cetirizine: a review of its use in allergic disorders.

Authors:  Monique P Curran; Lesley J Scott; Caroline M Perry
Journal:  Drugs       Date:  2004       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.